Medtronic plc.

Open: 86.0 Close: 85.79 Change: -0.21

How to get informed about Medtronic plc. Stock quickly using an AI.

How much time have you spent trying to decide whether investing in Medtronic plc.? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: …

Concept Map

Semantic Network

Stock Summary

Medtronic plc develops, manufactures, and sells device-based medical therapies. Cardiovascular, medical, surgical, and Neuroscience Portfolio segments offer products for spinal surgeons, neurosurgeons, neurologists, neurologist, pain management.

Today's Summary

Medtronic PLC (NYSE: MDT) closing price: 83.60 Support price level: $81.44 Resistance price level is $86.90 Relative strength index (14-day RSI) Volatility is forecast.

Today's News

Medtronic PLC (NYSE: MDT) closing price: 83.60 Support price level: $81.44 Resistance price level is $86.90 Relative strength index (14-day RSI) Volatility is forecast to fall over the next month. Medtronic PulseSelect PFA system is now FDA-approved, and CE marked, and all of the trials of PFA systems show its safer and faster than existing ablation modalities with a fairly short learning curve. Theres work to do. Medtronic is sponsoring trials looking at other indications. Medtronic is in the Health Care sector and Health Care Equipment & Supplies industry. Q4 earnings are confirmed for Thursday, May 23, 2024. Medtronic has received 510(k) clearance from the US Food and Drug Administration (FDA) for the OsteoCool 2.0 ablation system to treat painful bone metastases. Medtronics plans to commence a limited market release of the system immediately. Medtronic (MDT) reported earnings of $1.30 per share, beating the Zacks Consimate of $0.30. Medtronics has filed a complaint with the U.S. District Court for the District of Delaware. Medtronic once again named one of the worlds most ethical companies for the second consecutive year by Ethisphere. The companys OsteoCool radiofrequency ablation system offers a number of new advantages. Medtronic PLC-Bond has amaturity date of 3/15/2045 and offers a coupon of 4.6250% About the Medtronics PLC bond (US585055BU98) The Medtony PLC Bond has am aturity date. of 3.45 and offer a coupon. of 46250%. Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Medtronic ( MDT – Research Report ) today and set a price target of $100.00. Oppenheimer maintained a Hold rating on the company today.

Stock Profile

"Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland."

Keywords

The game is changing. There is a new strategy to evaluate Medtronic plc. fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, system, price, PLC, MDT, ablation, Medtronics, and the most common words in the summary are: medtronic, stock, mdt, company, buy, plc, market, . One of the sentences in the summary was: Medtronic PLC (NYSE: MDT) closing price: 83.60 Support price level: $81.44 Resistance price level is $86.90 Relative strength index (14-day RSI) Volatility is forecast.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #medtronic #stock #mdt #company #buy #plc #market.